RxDoctor Payments DataLook up a doctor →

Mark Jenson, MD

Family Medicine · Green Bay, WINPI 1598727000

Payments from drug & device makers

$204,421in general payments, 2019–2025

Across 1,270 payments — averaging $160.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$164K
  • Shire North American Group Inc$22K
  • AbbVie$2K
  • Lilly USA, LLC$2K
  • Amgen$1K
  • AstraZeneca$1K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Takeda Pharmaceuticals U.S.A., Inc.193$164,353
Shire North American Group Inc28$22,118
AbbVie(2 entities)153$2,125
Lilly USA, LLC105$1,532
Amgen73$1,223
AstraZeneca(2 entities)46$1,195
Pfizer69$1,130
Novo Nordisk101$1,114
Otsuka America Pharmaceutical, Inc.40$949
Johnson & Johnson(3 entities)41$830
Boehringer Ingelheim41$681
Supernus Pharmaceuticals, Inc.38$618
Teva Pharmaceuticals USA, Inc.20$415
Gilead16$345
Almatica Pharma LLC17$307
Ironshore Pharmaceuticals Inc.17$289
Merck23$285
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$264
Corium, LLC14$256
Novartis13$241
Tris Pharma Inc5$203
Bayer10$203
Amarin Pharma, Inc.10$192
Sumitomo Pharma America, Inc.8$183
E.r. Squibb & Sons, L.L.C.13$182
Sanofi-aventis U.S. LLC10$167
Astellas Pharma US Inc4$167
Abbott10$166
Collegium Pharmaceutical, Inc.8$164
Acadia Pharmaceuticals Inc11$162
Scilex Pharmaceuticals Inc.10$157
Biohaven Pharmaceutical Holding Company Ltd.10$148
Lundbeck LLC6$141
Esperion Therapeutics, Inc.7$140
Axsome Therapeutics, Inc.7$137
Neurocrine Biosciences, Inc.5$134
Biohaven Pharmaceuticals, Inc.4$132
Pacira Therapeutics, Inc.7$127
Lexicon Pharmaceuticals, Inc.6$122
Kowa Pharmaceuticals America, Inc.7$113
Covis Pharma GmbH4$100
Alkermes, Inc.4$84
Exact Sciences4$80
Avanir Pharmaceuticals, Inc.4$78
Vanda Pharmaceuticals Inc.4$75
GSK4$71
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$71
Mallinckrodt Hospital Products Inc.3$66
Sanofi Pasteur Inc.3$59
Dexcom, Inc.3$46
Neos Therapeutics, LP3$43
Ironwood Pharmaceuticals, Inc2$38
Phathom Pharmaceuticals, Inc.2$36
Bausch Health US, LLC2$33
Electronic Waveform Lab, Inc.2$25
Aimmune Therapeutics, Inc.1$24
Bioventus LLC1$23
Xeris Pharmaceuticals, Inc.1$19
Hologic Sales And Service, LLC1$14
Eisai Inc.1$14

How this compares

$204,421 in reported general payments places this provider in the 95th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin →

Medicare billing

Part B allowed, 2024
$35,139
Medicare patients
98
Services billed
2,133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Green Bay

See the full list for Wisconsin →

Where these figures come from

Is this you, or does something look wrong? →